
|Articles|February 2, 2022
Daily Medication Pearl: Armodafinil (Nuvigil)
Author(s)Saro Arakelians, PharmD
Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents.
Advertisement
Medication Pearl of the Day: Armodafinil (Nuvigil)
Indication: Armodafinil is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).
Insight:
- Dosing: OSA or narcolepsy 150 mg to 250 mg once a day in the morning.
- Dosage forms: Tablets 50 mg, 150 mg, 200 mg, and 250 mg.
- Adverse events: Most common adverse reactions (³5%) are headache, nausea, dizziness, and insomnia.
- Mechanism of action: Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents, including amphetamine and methylphenidate, although their pharmacologic profile is not identical to that of the sympathomimetic amines.
- Manufacturer: Teva Pharma
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen-Naproxen Combination for 12-Hour Pain Relief
2
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
3
Online GLP-1 Sellers Often Skip Clinician Oversight, Secret Shopper Study Finds
4
“Can I Take This With My Other Medicine?”: Understanding Drug Interactions
5











































































































